Astellas Pharma has submitted an NDA to Japan's Ministry of Health, Labour and Welfare seeking conditional approval of ACP.
Three people with a muscle-destroying disease destined to worsen got a little stronger - able to stand and walk more easily - ...
Three people with a muscle-destroying disease destined to worsen got a little stronger – able to stand and walk more easily – ...
A study of NCAA Division I football players revealed persistent atrophy in the quadriceps and gastrocnemius muscles 2 years ...